Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Sleep Initiation and Maintenance Disorders
Clinical Trial
NCT00283946Last updated: 12/5/2025
4503.T
Astellas Pharma Inc.
